This appeal is backed by the Canadian Covid Care Alliance (CCCA).
https://www.canadiancovidcarealliance.org/
COVID shots were just the beginning. The pharmaceutical industry is developing all kinds of new mRNA drugs for humans and livestock. mRNA drugs are cheap and easy to make. And now the Canadian government is about to get rid of those pesky requirements for safety testing before approval of new drugs.
The new legislation is called “Agile Licensing of advanced therapeutic products”. This will permanently entrench the lax regulatory standards that were used to approve Covid vaccines at warp speed. The changes will allow for easy and quick approval of new and high-risk drugs and “therapies” for humans and farm animals.
We have overwhelming proof that mRNA “vaccines” are not safe but they are still being pushed on us. Once drugs have received approval it is very difficult to take them off the market. The burden of proof, which takes a lot of money, is shifted from the pharmaceutical industry to regular taxpayers. The lax approvals will apply to all new drugs in Canada unless we can raise enough concern before April 26th (this Monday).
To look at what this means for our future health, here’s a brief review of how COVID mRNA shots were approved, based on research and testimony by medical scientist Deanna McLeod of CCCA at the National Citizens Inquiry (NCI) on April 13 in Winnipeg, starting at 5 hours & 43 minutes into this video.
https://rumble.com/v2hz2rc-national-citizens-inquiry-winnipeg-day-1.html.
Deanna’s sister died after receiving a COVID shot.
· The “vaccines” were approved in less than one year, when 15 years of intensive testing was formerly required.
· Drug makers no longer needed to prove safety, just to provide “evidence of safety”.
· Manufacturers were given indemnity from drug-injury-compensation requirements.
· Rats were used in preclinical trials, even though rats are not good indicators of human effects.
· Phases 1, 2 and 3 of clinical trials were combined and severely shortened.
· Clinical trials were conducted only on low-risk people, before rolling out to high-risk groups.
· There was minimal to no monitoring of basic safety signals such as inflammatory markers, and no careful scrutiny after seven days.
· After 2 months of the phase 1 human clinical trial, the placebo group was offered the vaccine, and about 75% of participants were vaxed. This means there is no way to monitor long-term issues.
· Previously required testing for neurotoxicity (effects on the brain), teratogenicity (effects on the fetus), and oncogenicity (cancer), were not done.
THREE URGENT ACTIONS ARE REQUIRED BEFORE APRIL 26!
1. Submit a ‘General Comment' about “Agile Licensing” at the top of this Government of Canada website. https://canadagazette.gc.ca/rp-pr/p1/2022/2022-12-17/html/reg1-eng.html
2. Email the same comments in a letter to Bruno Rodrigue, Executive Director, Office of Legislative and Regulatory Modernization, Health Products and Food Branch, Department of Health, 3000A, 11 Holland Avenue, Suite P2108, Ottawa, Ontario K1A 0K9 (email: lrm.consultations-mlr@hc-sc.gc.ca).
3. Contact your MP to express your concern about “Agile Licensing”. Find your Member of Parliament here: https://www.ourcommons.ca/members/en/search
a. Lethbridge: Rachael Thomas,
rachael.thomas@parl.gc.ca; 403-320-0070; 613-992-4516
b. Bow River: Martin Shields,
martin.shields@parl.gc.ca; 403-361-2980; 613-992-0761
c. Foothills: John Barlow,
john.barlow@parl.gc.ca; 403-603-3665; 613-995-8471
d. Medicine Hat - Cardston - Warner: Glen Motz,
glen.motz@parl.gc.ca; 1-844-781-9061; 613-996-0633
Things to Tell the Government:
· Demand an immediate stop to all Agile Licensing regulations and proposed amendments and demand an investigation into the individuals involved in creating this industry-favoring backdoor that places Canadians at risk of product harm by rushing novel products to the market without first proving their safety and efficacy.
· Say NO to any and all food and drug regulatory amendments that would permit the authorization of any product or device that has not first been PROVEN safe and effective through rigorously conducted randomized and controlled trials.
· Insist on an immediate re-examination of the ATP framework and all proposed regulatory changes to the Food and Drugs Act by qualified, INDEPENDENT health professionals and public representatives who are free from conflicts of interest.
· Demand that Canadian safety be re-prioritized by setting prudent, transparent, objective safety criteria for all products and devices that cannot be manipulated for political or economic gain.
· Send a clear message: The “speed of science” should never outpace public safety. The government should not let Big Pharma cut corners on safety, with people suffering as a result.
Here is sample letter for submission to the Gazette and to Mr. Bruno Rodrigue:
Attn: Bruno Rodrigue, Executive Director
Office of Legislative and Regulatory Modernization
Health Products and Food Branch
Department of Health, 3000A
11 Holland Avenue, Suite P2108
Ottawa, Ontario K1A 0K9
lrm.consultations-mlr@hc-sc.gc.ca
Dear Mr. Bruno Rodrigue:
I am contacting you to express my concerns about the proposed regulatory changes that will push innovation over safety.
Historically Canada has held to the highest regulatory standards by ensuring all medical products were PROVEN SAFE and effective prior to being released to the public, using Randomized Controlled Trials to ensure that the benefits outweigh the risks.
I am opposed to the Part I, Volume 156, Number 51: Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Agile Licensing) and any other regulatory changes that would remove the requirement that all drugs, medical devices, veterinary and similar products are first PROVEN safe through rigorously conducted randomized controlled trials BEFORE market authorization. I am also opposed to changes that centralize the process and increase the control of a single individual, such as the Minister of Health.
No civilized society would ever sacrifice the safety of their citizens on the altar of innovation.
All Canadians deserve to have a government and bureaucracy that are committed to putting their interests first and maintaining the highest safety standards. Therefore, I insist on an immediate re-examination of the Advanced Therapeutic Products Pathway and all proposed regulatory changes to the Food and Drugs Act, by qualified independent health professionals and public representatives who are free from conflicts of interest and who will ensure that all products are proven safe before being given market authorization.
Health Canada has a fiduciary responsibility to protect Canadians from pharmaceutical abuse and not to promote innovation.
I further insist that the safety of Canadians be re-prioritized by setting prudent, transparent, objective, safety criteria for ALL products and devices that cannot be manipulated for political or economic gain.
Sincerely,
(Your Name)